Press release
Glaucoma Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire
DelveInsight's "Glaucoma Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Glaucoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Glaucoma Market Forecast [https://www.delveinsight.com/sample-request/glaucoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Glaucoma Market Report:
* The Glaucoma market size was valued approximately USD 4,073 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
* In June 2023, Ciliatech's implantable device for glaucoma patients is nearing regulatory approval following the disclosure of favorable outcomes from a subsequent two-year post-operative clinical trial.
* In 2022, the Glaucoma market in the US stood out with the highest market size, reaching USD 2,571 million in net sales revenue among the 7MM. Conversely, the UK exhibited the lowest market size, with approximately USD 132 million.
* In 2022, it was estimated that there were approximately 7,045,443 diagnosed prevalent cases of Glaucoma in the 7MM. However, the total burden of Glaucoma, including both diagnosed and undiagnosed cases, was estimated to be around 16,632,421 in the same year across the 7MM.
* The overall Glaucoma market size is projected to increase in the forecast period, driven by the anticipated introduction of emerging therapies such as iDose TR (travoprost intraocular implant), NCX 470, PDP-71, and other treatments.
* Glaucoma often goes unnoticed in a majority of patients due to various factors. DelveInsight's estimates indicate that out of the 16,632,421 prevalent Glaucoma cases in the 7MM in 2022, only around 7,045,443 cases are believed to have been formally diagnosed.
* Key Glaucoma Companies: SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire Pharma, Kowa, Bayer, Alcon Research, Pfizer, Merck Sharp & Dohme LLC, Quark Pharmaceuticals, and others
* Key Glaucoma Therapies: PDP-716, PRO-122, EYBELIS/Omidenepag isopropyl/DE-117, DE-130A, Sepetaprost (DE-126/ONO9054), NCX-470, Nyxol, K-232, Aflibercept (Eylea, BAY 86-5321), Travoprost, timolol/dorzolamide, QPI-1007, and others
* Glaucoma can impact individuals of both genders, but the ratio of male to female Glaucoma patients indicates a higher prevalence among females. In 2022, there were approximately 3,234,796 cases of Glaucoma among males and 3,810,646 cases among females.
* The Glaucoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Glaucoma pipeline products will significantly revolutionize the Glaucoma market dynamics.
Glaucoma Overview
Glaucoma is a disease that damages the eye's optic nerve. It usually happens when fluid builds up in the front part of the eye. That extra fluid increases the pressure in eye, damaging the optic nerve. The condition is a leading cause of blindness for people over 60 years old. But blindness from glaucoma can often be prevented with early treatment. There are two main types of glaucoma - primary and secondary
Get a Free sample for the Glaucoma Market Report:
https://www.delveinsight.com/report-store/glaucoma-market [https://www.delveinsight.com/report-store/glaucoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Glaucoma Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Glaucoma Epidemiology Segmentation:
The Glaucoma market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
* Total Prevalence of Glaucoma
* Prevalent Cases of Glaucoma by severity
* Gender-specific Prevalence of Glaucoma
* Diagnosed Cases of Episodic and Chronic Glaucoma
Download the report to understand which factors are driving Glaucoma epidemiology trends @ Glaucoma Epidemiology Forecast [https://www.delveinsight.com/sample-request/glaucoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Glaucoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Glaucoma market or expected to get launched during the study period. The analysis covers Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Glaucoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Glaucoma Therapies and Key Companies
* NCX-470: Nicox Ophthalmics
* TRS01: Tarsier Pharma
* PDP-716: SPARC
* PRO-122: Laboratories Sophia
* EYBELIS/Omidenepag isopropyl/DE-117: Santen Pharmaceutical
* DE-130A: Santen Pharmaceutical
* Sepetaprost (DE-126/ONO9054): Santen Pharmaceutical
* Nyxol: Ocuphire Pharma
* K-232: Kowa
* Aflibercept (Eylea, BAY 86-5321): Bayer
* Travoprost: Alcon Research
* Timolol: Pfizer
* timolol/dorzolamide: Merck Sharp & Dohme LLC
* QPI-1007: Quark Pharmaceuticals
Discover more about therapies set to grab major Glaucoma market share @ Glaucoma Treatment Market [https://www.delveinsight.com/sample-request/glaucoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Glaucoma Market Drivers
* Rich emerging pipeline
* Development of advanced antiglaucoma medications
* Development of treatment methods to tackle the situation of non-adherence
* Patients-friendly dosage regimes
* Rise in awareness
Glaucoma Market Barriers
* Approaches to clinical practice
* Socioeconomic barriers
* Lack of patient pool due to under diagnosis
Scope of the Glaucoma Market Report
* Study Period: 2020-2034
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Glaucoma Companies: SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire Pharma, Kowa, Bayer, Alcon Research, Pfizer, Merck Sharp & Dohme LLC, Quark Pharmaceuticals, and others
* Key Glaucoma Therapies: PDP-716, PRO-122, EYBELIS/Omidenepag isopropyl/DE-117, DE-130A, Sepetaprost (DE-126/ONO9054), NCX-470, Nyxol, K-232, Aflibercept (Eylea, BAY 86-5321), Travoprost, timolol/dorzolamide, QPI-1007, and others
* Glaucoma Therapeutic Assessment: Glaucoma current marketed and Glaucoma emerging therapies
* Glaucoma Market Dynamics: Glaucoma market drivers and Glaucoma market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Glaucoma Unmet Needs, KOL's views, Analyst's views, Glaucoma Market Access and Reimbursement
To know more about Glaucoma companies working in the treatment market, visit @ Glaucoma Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/glaucoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Glaucoma Market Report Introduction
2. Executive Summary for Glaucoma
3. SWOT analysis of Glaucoma
4. Glaucoma Patient Share (%) Overview at a Glance
5. Glaucoma Market Overview at a Glance
6. Glaucoma Disease Background and Overview
7. Glaucoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Glaucoma
9. Glaucoma Current Treatment and Medical Practices
10. Glaucoma Unmet Needs
11. Glaucoma Emerging Therapies
12. Glaucoma Market Outlook
13. Country-Wise Glaucoma Market Analysis (2020-2034)
14. Glaucoma Market Access and Reimbursement of Therapies
15. Glaucoma Market Drivers
16. Glaucoma Market Barriers
17. Glaucoma Appendix
18. Glaucoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=glaucoma-market-to-observe-impressive-growth-during-the-forecast-period-20242034-evaluates-delveinsight-bayer-sparc-laboratories-sophia-santen-pharmaceutical-nicox-ophthalmics-ocuphire]
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire here
News-ID: 3462294 • Views: …
More Releases from ABNewswire
CRM + Booking Integration: How Bitrix24 Is Revolutionizing Business Operations i …
Image: https://www.abnewswire.com/upload/2025/08/3b1b46307a609effec9c81b325e7a4d9.jpg
In today's hyper-competitive business landscape, the integration of Customer Relationship Management (CRM) systems with booking platforms has become more than just a convenience - it's a strategic necessity that's transforming how successful companies operate.
Leading this revolution is Bitrix24, whose innovative CRM with Booking solution [https://www.bitrix24.com/tools/websites/landing-pages.php] has helped over 15 million organizations worldwide streamline their operations and boost revenue by up to 30%. As we navigate through 2025, businesses that…
VidMate Redefines Digital Entertainment with Seamless Video and Music Downloads
Image: https://www.abnewswire.com/upload/2025/08/36d7b33dce79622e8d8df37fff6f9e2f.jpg
Introduction
In today's digital world, streaming videos, music, and images has become a daily routine for millions of people. However, many users often struggle with unreliable internet connections, limited storage options, or restrictions from platforms that do not allow direct downloads. This is where VidMate, a free Android application, becomes the perfect solution.
VidMate enables users to download videos, music, and pictures in high quality from almost any platform, including YT,…
Vograce Introduces High-Quality Custom Acrylic Keychains for Creative Branding S …
Image: https://www.abnewswire.com/upload/2025/08/96fd20a79da68a1056770c7a31d077f7.jpg
Introduction: Why Custom Acrylic Keychains Are a Smart Choice
At one time or another, you may have considered practices that can give your brand, event or beats a boost but custom acrylic keychains are one of the most cost effective yet dynamic options you can utilize. They are tiny, convenient and attractive. Nonetheless, not every keychain is good. Poor quality printing, substandard paper, or lifeless colors will make their appearance…
Medical Monks Launches Essential Ostomy Resource Guide to Empower Senior Patient …
Image: https://www.abnewswire.com/upload/2025/08/c3a8c482db6e9c2d73591d2b822fe1b6.jpg
As our bodies get older, we start to wade through unchartered territories. Every couple of months there's a new urging issue that one needs to address. It's safe to say that sometimes growing older can feel tiring.
For those living with ostomies or older adults having to deal with an ostomy for the first time, it can be confusing and exhausting at the start, especially if you don't have guidance.…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
